ARIXTRA®
Solution for injection, 2.5 mg/0.5ml
HospitalActive license
Active substance (INN)
fondaparinux
Pharmaceutical form
Pharmaceutical formSolution for injection
Strength2.5 mg/0.5ml
Packagingukupno 10 napunjenih injekcionih špriceva (10x0.5ml), u kartonskoj kutiji
ManufacturerGlaxo Wellcome Production, France
Therapeutic groupBlood and blood forming organs (B01AX05)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateMay 29, 2013
Source: CInMED register